Overview

Infusion Pumps Market is poised to value over USD 21 billion by 2027 end at a CAGR of over 7% during the forecast period 2020 to 2027.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Infusion Pumps Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Infusion Pumps Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Infusion Pumps Market:
• Becton, Dickinson and Company
• B. Braun Melsungen AG
• Baxter International Inc.
• Fresenius Kabi 
• ICU Medical, Inc.
• Medtronic plc
• Moog Inc. 
• Smiths Medical 
• Terumo Corporation 
• Nipro Corporation 
• Avanos Medical, Inc. 
• Tandem Diabetes Care, Inc. 
• JMS Co., Ltd. 
• Insulet Corporation 
• Roche Diagnostics 
• Zyno Medical 
• Teleflex, Inc. 
• Mindray Medical International Limited 
• Micrel Medical Devices SA 
• Ypsomed Holding AG 
(Note: The list of the major players will be updated with the latest market scenario and trends)

Infusion Pumps Market Segmentation:
By Product
• Accessories & Consumables
    o Dedicated Accessories & Consumables
        o Volumetric Infusion Pumps
        o Insulin Infusion Pumps
        o Enteral Infusion Pumps
        o Syringe Infusion Pumps
        o Ambulatory Infusion Pumps
        o PCA Pumps
        o Implantable Infusion Pumps
   o Non-Dedicated Accessories & Consumables
        o Infusion Catheters
        o IV/Administration Sets
        o Needleless Connectors
        o Cannulas
        o Tubing & Extension Sets
        o Valves
        o Other Non-dedicated Accessories & Consumables
• Devices
   o By Product
        o Volumetric Infusion Pumps
        o Enteral Infusion Pumps
        o Ambulatory Infusion Pumps
              o Disposable Infusion Pumps
              o Chemotherapy Infusion Pumps
        o Syringe Infusion Pumps
        o Insulin Infusion Pumps
        o PCA Pumps
        o Implantable Infusion Pumps
   o By Type
        o Traditional Infusion Pumps
        o Specialty Infusion Pumps
By Application
• Chemotherapy/Oncology
• Diabetes
• Gastroenterology
• Analgesia/Pain Management
• Pediatrics/Neonatology
• Hematology
• Other Applications
By End User
• Hospitals
• Home Care Settings
• Ambulatory Care Settings
• Academic & Research Institutes
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Infusion Pumps Market By Product, By Application, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
   1.1. Objectives of the Study 
   1.2. Market Definition 
   1.3. Market Scope 
        1.3.1. Years Considered for the Study
        1.3.2. Market Covered
   1.4. Currency 
   1.5. Limitations 
   1.6. Stakeholders 

2. Research Methodology 
   2.1. Research Data 
        2.1.1. Secondary Data
               2.1.1.1. Key Data from Secondary Sources
        2.1.2. Primary Data
               2.1.2.1. Key Data from Primary Sources
   2.2. Market Size Estimation 
   2.3. Market Breakdown and Data Triangulation 
   2.4. Assumptions for the Study  

3. Executive Summary
   3.1. Market Outlook
   3.2. Segment Outlook
   3.3. Competitive Insights

4. Global Infusion Pumps Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Technology Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of Infusion Pumps Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Infusion Pumps Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Technology Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Technology Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. Infusion Pumps Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million)
   7.1. Accessories & Consumables
           7.1.1. Dedicated Accessories & Consumables
                     7.1.1.1. Volumetric Infusion Pumps
                     7.1.1.2. Insulin Infusion Pumps              
                     7.1.1.3. Enteral Infusion Pumps
                     7.1.1.4. Syringe Infusion Pumps
                     7.1.1.5. Ambulatory Infusion Pumps
                     7.1.1.6. PCA Pumps
                     7.1.1.7. Implantable Infusion Pumps
            7.1.2. Non-Dedicated Accessories & Consumables
                     7.1.2.1. Infusion Catheters
                     7.1.2.2. IV/Administration Sets                
                     7.1.2.3. Needleless Connectors
                     7.1.2.4. Cannulas
                     7.1.2.5. Tubing & Extension Sets
                     7.1.2.6. Valves
                     7.1.2.7. Other Non-dedicated Accessories & Consumables
   7.2. Devices
           7.2.1. By Product
                     7.2.1.1. Volumetric Infusion Pumps
          7.2.1.2. Enteral Infusion Pumps              
                     7.2.1.3. Ambulatory Infusion Pumps
                                   7.2.1.3.1. Disposable Infusion Pumps
                                   7.2.1.3.2. Chemotherapy Infusion Pumps
                     7.2.1.4. Syringe Infusion Pumps
                     7.2.1.5. Insulin Infusion Pumps
                     7.2.1.6. PCA Pumps
                     7.2.1.7. Implantable Infusion Pumps  
           7.2.2. By Type
                     7.2.2.1. Traditional Infusion Pumps
                     7.2.2.2. Specialty Infusion Pumps              

8. Global Infusion Pumps Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)  
   8.1. Chemotherapy/Oncology
   8.2. Diabetes
   8.3. Gastroenterology
   8.4. Analgesia/Pain Management
   8.5. Pediatrics/Neonatology
   8.6. Hematology
   8.7. Other Applications

9. Global Infusion Pumps Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)  
   9.1. Hospitals
   9.2. Home Care Settings
   9.3. Ambulatory Care Settings
   9.4. Academic & Research Institutes

10. North America Infusion Pumps Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    10.1. Introduction
    10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
          10.2.1. U.S.A
          10.2.2. Canada
          10.2.3. Mexico
    10.3. Market Size (USD Million) Forecast for North America 2020-2027

11. Latin America Infusion Pumps Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    11.1. Introduction
    11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
          11.2.1. Brazil
          11.2.2. Venezuela
          11.2.3. Argentina
          11.2.4. Rest of Latin America
    11.3. Market Size (USD Million) Forecast for Latin America 2020-2027

12. Europe Infusion Pumps Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    12.1. Introduction
    12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
          12.2.1. Germany
          12.2.2. U.K         
          12.2.3. France
          12.2.4. Italy
          12.2.5. Spain
          12.2.6. Russia
          12.2.7. Poland
          12.2.8. Rest of Europe
    12.3. Market Size (USD Million) Forecast for Europe 2020-2027

13. Asia Pacific Infusion Pumps Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
          13.2.1. Japan
          13.2.2. China
          13.2.3. India
          13.2.4. Australia and New Zealand
          13.2.5. ASEAN
          13.2.6. Rest of Asia Pacific
    13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027  

14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    14.1. Introduction
    14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
          14.2.1. Saudi Arabia
          14.2.2. UAE
          14.2.3. South Africa
          14.2.4. Egypt
    14.3. Market Size (USD Million) Forecast for MEA 2020-2027

15. Market Share Analysis and Competitive Landscape   
    15.1. Global Landscape - Key Players, Revenue and Presence
    15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    15.3. Global Emerging Companies
    15.4. North America - Market Share Analysis and Key Regional Players
    15.5. Europe - Market Share Analysis and Key Regional Players
    15.6. Asia Pacific - Market Share Analysis and Key Regional Players
    15.7. Global Key Player - Growth Matrix

16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    16.1. Becton, Dickinson and Company
          16.1.1. Company Overview
          16.1.2. Product Portfolio
          16.1.3. SWOT Analysis
          16.1.4. Financial Overview
          16.1.5. Strategic Overview
    16.2. B. Braun Melsungen AG
          16.2.1. Company Overview
          16.2.2. Product Portfolio
          16.2.3. SWOT Analysis
          16.2.4. Financial Overview
          16.2.5. Strategic Overview 
    16.3. Baxter International Inc.
          16.3.1. Company Overview
          16.3.2. Product Portfolio
          16.3.3. SWOT Analysis
          16.3.4. Financial Overview
          16.3.5. Strategic Overview
    16.4. Fresenius Kabi
          16.4.1. Company Overview
          16.4.2. Product Portfolio
          16.4.3. SWOT Analysis
          16.4.4. Financial Overview
          16.4.5. Strategic Overview
    16.5. ICU Medical, Inc.
          16.5.1. Company Overview
          16.5.2. Product Portfolio
          16.5.3. SWOT Analysis
          16.5.4. Financial Overview
          16.5.5. Strategic Overview          
    16.6. Medtronic plc
          16.6.1. Company Overview
          16.6.2. Product Portfolio
          16.6.3. SWOT Analysis
          16.6.4. Financial Overview
          16.6.5. Strategic Overview      
    16.7. Moog Inc.
          16.7.1. Company Overview
          16.7.2. Product Portfolio
          16.7.3. SWOT Analysis
          16.7.4. Financial Overview
          16.7.5. Strategic Overview
    16.8. Smiths Medical
          16.8.1. Company Overview
          16.8.2. Product Portfolio
          16.8.3. SWOT Analysis
          16.8.4. Financial Overview
          16.8.5. Strategic Overview 
    16.9. Terumo Corporation
          16.9.1. Company Overview
          16.9.2. Product Portfolio
          16.9.3. SWOT Analysis
          16.9.4. Financial Overview
          16.9.5. Strategic Overview 
    16.10. Nipro Corporation
          16.10.1. Company Overview
          16.10.2. Product Portfolio
          16.10.3. SWOT Analysis
          16.10.4. Financial Overview
          16.10.5. Strategic Overview 
    16.11. Avanos Medical, Inc.
          16.11.1. Company Overview
          16.11.2. Product Portfolio
          16.11.3. SWOT Analysis
          16.11.4. Financial Overview
          16.11.5. Strategic Overview      
    16.12. Tandem Diabetes Care, Inc.
          16.12.1. Company Overview
          16.12.2. Product Portfolio
          16.12.3. SWOT Analysis
          16.12.4. Financial Overview
          16.12.5. Strategic Overview
    16.13. JMS Co., Ltd.
          16.13.1. Company Overview
          16.13.2. Product Portfolio
          16.13.3. SWOT Analysis
          16.13.4. Financial Overview
          16.13.5. Strategic Overview 
    16.14. Insulet Corporation
          16.14.1. Company Overview
          16.14.2. Product Portfolio
          16.14.3. SWOT Analysis
          16.14.4. Financial Overview
          16.14.5. Strategic Overview
    16.15. Roche Diagnostics
          16.15.1. Company Overview
          16.15.2. Product Portfolio
          16.15.3. SWOT Analysis
          16.15.4. Financial Overview
          16.15.5. Strategic Overview
    16.16. Zyno Medical
          16.16.1. Company Overview
          16.16.2. Product Portfolio
          16.16.3. SWOT Analysis
          16.16.4. Financial Overview
          16.16.5. Strategic Overview          
    16.17. Teleflex, Inc.
          16.17.1. Company Overview
          16.17.2. Product Portfolio
          16.17.3. SWOT Analysis
          16.17.4. Financial Overview
          16.17.5. Strategic Overview      
    16.18. Mindray Medical International Limited
          16.18.1. Company Overview
          16.18.2. Product Portfolio
          16.18.3. SWOT Analysis
          16.18.4. Financial Overview
          16.18.5. Strategic Overview
    16.19. Micrel Medical Devices SA
          16.19.1. Company Overview
          16.19.2. Product Portfolio
          16.19.3. SWOT Analysis
          16.19.4. Financial Overview
          16.19.5. Strategic Overview 
     16.20. Ypsomed Holding AG
          16.20.1. Company Overview
          16.20.2. Product Portfolio
          16.20.3. SWOT Analysis
          16.20.4. Financial Overview
          16.20.5. Strategic Overview 

17. Pre and Post COVID-19 Impact
    17.1. Positive influence on the healthcare industry
    17.2. The financial disruption of the manufacturing sector
    17.3. Impact of COVID-19 on emerging companies
    17.4. Significant mandates in the healthcare regulations initiated by administrations
    17.5. The overall economic slowdown of the developing and developed nations

18. FutureWise SME Key Takeaway Points for Client

Tables

Figures